International Cancer Cluster Showcase (ICCS) has been organized since 2012 as a satellite event to the BIO International Convention in the US.
It is a joint initiative with partners from Europe and North America. The next ICCS is taking place June 3rd, 2019 in Philadelphia.
11:30 – 12:30 p.m.
REGISTRATION AND LIGHT LUNCH with POSTER SESSION
12:30 – 12:45 p.m.
Opening and Welcome by ICCS Organizing Partners and Sponsors
Welcome Notes: Allison Hilton, Healthcare Corporate Banking, DNB Healthcare & Larry Blandford, Executive Vice President, Precision Value & Health
12:45 – 1:15 p.m.
Company Pitches – I
Kernal, ISOMA Therapeutics, Vaccibody, Memo Therapeutics, Chimeric Therapeutics, Ability Pharma
1:15 – 1:20 p.m.
Takeda Oncology Presentation
Chris Hurff, Senior Director Business Development, Takeda Oncology
1:20 – 1:45 p.m.
Company Pitches – II
OncoInvent, Vironika, Cytosolix, eTheRNA, Neophore
1:45 – 1:50 p.m.
National Cancer Institute (NCI) Presentation
Michael Salgaller, Supervisory Specialist Technology Transfer Center, NCI, National Institutes of Health
1:50 – 2:15 p.m.
NETWORKING BREAK & POSTER SESSION
2:15 – 2:20 p.m.
Boehringer Ingelheim Presentation
Marcio Lasaro, Associate Director Cancer Immunology and Biotherapeutics Business Development and Licensing
2:20 – 2:50 p.m.
Company Pitches – III
Domain Therapeutics, Carisma Therapeutics, BioInvent, Biomunex, Bryologics, Valo Therapeutics
2:50 – 3:00 p.m.
Mass Medical Angels
3:00 – 3:30 p.m.
Company Pitches – IV
BioArray Genetics, RS Research, Virion Therapeutics, KisoJi Biotechnology, Oncoheroes
3:30 – 3:35 p.m.
3:35 – 4:30 p.m.
NETWORKING RECEPTION & POSTER SESSION
Profiles of all the presenting companies and more information can be found on the official International Cancer Cluster Showcase website.